Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall.
BACKGROUND
-Recent studies have suggested that testosterone has a protective effect in the arterial vascular system. However, little is known about the molecular aspects of the mechanism(s) involved in these processes. The aim of the present study was to investigate the effect of testosterone on neointimal plaque development and on the expression of the vascular androgen receptor. Methods and Results-Neointimal plaque formation was induced by endothelial denudation in the aortas of male New Zealand White rabbits. Aortic ring segments were cultured for 21 days after endothelial denudation. Testosterone was applied to the culture medium in different doses. Compared with the non-hormone-treated control group, a significant inhibition of neointimal plaque development (expressed as the intima/media ratio) was found at testosterone concentrations of 10 ng/mL (P:=0.037) and 100 ng/mL (P:=0.012; intima/media ratios: median of controls, 0.25; median of 10 ng/mL testosterone group, 0.15; median of 100 ng/mL testosterone group, 0.16). Associated with this inhibitory effect on plaque size was a 50% increase of the amount of androgen receptor mRNA in the arterial segments treated with testosterone.


CONCLUSIONS
-The beneficial effects of testosterone on postinjury plaque development underlines, at least in males, the important role of androgens in the vascular system. As our data suggest, the vascular androgen receptor is probably involved in these processes. Further studies are required to characterize the androgen receptor-dependent pathways in the vascular system.
Hanke
H
H
Department of Internal Medicine/Cardiology, University of Ulm, Germany. hartmut.hanke@medizin.uni-ulm.de
Lenz
C
C
Hess
B
B
Spindler
K D
KD
Weidemann
W
W
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002318:Cardiovascular Diseases / Q000378:metabolism / Q000473:pathology* / Q000517:prevention & control; D004195:Disease Models, Animal; D012739:Gonadal Steroid Hormones / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D011817:Rabbits; D011944:Receptors, Androgen / Q000096:biosynthesis / Q000187:drug effects / Q000502:physiology*; D013739:Testosterone / Q000494:pharmacology* / Q000627:therapeutic use; D017539:Tunica Intima / Q000187:drug effects* / Q000473:pathology
D012739:Gonadal Steroid Hormones; D011944:Receptors, Androgen; D013739:Testosterone